Promo code APP3 – £3 discount on your first order in app 
Free delivery for orders over £49 
AeroBleu Nebulizer Solution with Seawater and Hyaluronic Acid, 5 ml, 20 vials, Bleu Pharma
AeroBleu Nebulizer Solution with Seawater and Hyaluronic Acid, 5 ml, 20 vials, Bleu Pharma
Description
AeroBleu nebulization solution based on seawater and hyaluronic acid 5 ml, 20 ampoules, Bleu Pharma helps maintain respiratory tract health. Properties: helps repair damaged lung tissues, ensuring faster healing; retains water, keeping the airways moist and facilitating mucus elimination; reduces inflammation, which reduces edema. Administration: 3 ampoules 3 times a day. Ingredients: Seawater; Sodium hyaluronate. Precautions: Hypersensitivity to one of the ingredients. Pregnant or breastfeeding women should consult a doctor before administration. Presentation: 20 single-dose ampoules x 5 ml
Features
| Product code | 899928 |
| Category | ENT care, Vitamins & Supplements |
| Product line | Hyaluronic acid |
| Brand | Bleu Pharma |
| Quantity | 20 |
| Volume | 100 ml |
| Dose | 5 ml |
AeroBleu Nebulizer Solution with Seawater and Hyaluronic Acid, 5 ml, 20 vials, Bleu Pharma
AeroBleu Nebulizer Solution with Seawater and Hyaluronic Acid, 5 ml, 20 vials, Bleu Pharma
By
Bleu Pharma
Delivery from Romania
Romania 
21 - 24 Aug
21 - 24 Aug
Guaranteed delivery from Romania: 21 - 24 August
-
£18.80Delivery: £5.99 (free from £49)
Delivery from Romania:
21 - 24 August
-
Pay securely with your preferred payment method 
£3 off your first order from £39 with promo code APP3
Recently viewed products
More products by Bleu Pharma
More products
Reviews
AeroBleu Nebulizer Solution with Seawater and Hyaluronic Acid, 5 ml, 20 vials, Bleu Pharma
Earn £1 Reward for every review
- For each submitted and approved review you can earn £1 Reward on your Rewards Credit.
- Rewards are given once for each purchased product you have reviewed.
- You have to be authorised to receive Rewards
All reviews
There are no reviews for this product.
Thank you for your review! It has been sent for moderation.
Description 
